migraine epidemiology forecast insight

DelveInsight’s ‘Migraine–Epidemiology Forecast—2034’ report delivers an in-depth understanding of the migraine, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Migraine Disease Understanding

Migraine is a neurological condition that can cause multiple symptoms. It is frequently characterized by intense, debilitating headaches. A migraine is a moderate or severe headache felt as a throbbing pain on one side of the head. Symptoms may include nausea, vomiting, difficulty speaking, numbness or tingling, and sensitivity to light and sound. Migraines often run in families and affect all ages.

The exact cause of migraines is unknown, but they are thought to be the result of abnormal brain activity temporarily affecting nerve signals, chemicals and blood vessels in the brain. Many possible migraine triggers have been suggested, including hormonal, emotional, physical, dietary, environmental and medicinal factors. These triggers vary among individuals, but a diary may help keep track of consistent trigger.

Spontaneous over activity and abnormal amplification in pain and other, predominantly sensory, pathways in the brainstem leads to migraine. Current opinion favors a primarily neural cause involving feedback loops through innervation of cranial arteries in the trigeminovascular system. The most common categories of migraine headache are those without aura (previously known as common migraines) and those with aura (previously known as classic migraines).

Episodic migraine (EM) is characterized by those with migraine who have 0–14 headache days per month; it is classified into low-frequency EM (less than 10 headache days per month) and high-frequency EM (10–14 headache days per month), while chronic migraine (CM) is characterized by 15 or more headache days per month.

There is no specific test to diagnose migraines. For an accurate diagnosis to be made, one must identify a pattern of recurring headaches along with the associated symptoms. The diagnosis of migraine headaches is determined based on clinical history, reported symptoms, and by ruling out other causes. Imaging scans, such as a CT scan or MRI, can rule out other causes, including tumors, strokes, bleeding in the brain, infections, and other brain and nervous system (neurological) conditions.

Migraine Epidemiology

The Migraine epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Migraine epidemiology segmented as the Total Prevalent Cases of Migraine, Severity-specific cases of Migraine, Gender-specific cases of Migraine, Diagnosed Cases of Episodic and Chronic Migraine. The report includes the Incident scenario of Migraine symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country Wise- Migraine Epidemiology

The epidemiology segment also provides the Migraine epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The total prevalent population of migraine in 7MM countries was 118,126 cases in 2020 and expected to increase for the study period, i.e., 2021-2034.

• As per the estimates, the United States has the highest Incident population of migraine in 7MM.
• Among the EU5 countries, Germany had the highest Incident population of migraine. On the other hand, Spain had the lowest number of cases, as 9,263 cases in 2020.

Scope of the Report

• Migraine report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
• Migraine Epidemiology Report and Model provide an overview of the risk factors and global trends of migraine in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of migraine in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM concerning the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of migraine
• The report provides the segmentation of the Migraine epidemiology by Incident Cases of Migraine in 7MM
• The report provides the segmentation of the Migraine epidemiology by Etiology -specific Incident Cases of Migraine in 7MM

Report Highlights

• 10-year Forecast of Migraine epidemiology
• 7MM Coverage
• Total Incident Cases of Migraine
• Severity-specific Incidence of Migraine
• Gender-specific Cases of Migraine
• Diagnosed Cases of Episodic and Chronic Migraine.

KOL Views

We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population about migraine?
• What are the key findings of Migraine epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2025-2034)?
• What would be the total number of patients with migraine across the 7MM during the forecast period (2025-2034)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2025-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?
• What are the disease risk, burden, and unmet needs of migraine?
• What are the currently available treatments for migraine?

Reasons to buy

The Migraine Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Migraine market
• Quantify patient populations in the global Migraine market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Migraine therapeutics in each of the markets covered
• Understand the magnitude of Migraine population by its Incidence cases
• Understand the magnitude of Migraine population by its Types-specific cases
• The Migraine epidemiology report and model was written and developed by Masters and PhD level epidemiologists
• The Migraine Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population